Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial Rho GTPase 1 (MIRO1) is an atypical Rho GTPase anchored in the outer mitochondrial membrane and encoded by the RHOT1 gene. It contains two GTPase domains (N-terminal and C-terminal), EF-hand calcium-binding motifs, and a transmembrane region. MIRO1 plays a crucial role in mitochondrial trafficking along microtubules, mitochondrial dynamics, and cellular calcium homeostasis. It is essential for neuronal function, particularly in facilitating mitochondrial movement to energy-demanding locations and regulating mitophagy through interactions with proteins such as PINK1 and Parkin. MIRO1 dysfunction and mutations are implicated in neurodegenerative diseases (notably Parkinson’s disease), as well as various cancers, due to its involvement in mitochondrial quality control, apoptosis, and cellular metabolism[1][2][3][5].
Targeting of MIRO1 for proteasomal degradation (ubiquitination by Parkin after phosphorylation by PINK1)[1][5]; Modulation of mitochondrial arrest to facilitate mitophagy[1][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Rho GTPase 1 (MIRO1).